Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

1987 • 1,175 citations

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

1989 • 467 citations

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

1985 • 151 citations

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

1986 • 73 citations

Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.

1985 • 66 citations

Multicenter Phase II trial of etoposide in refractory small cell lung cancer.

1985 • 38 citations

Initial therapy with cisplatin plus VP-16 in small-cell lung cancer.

1986 • 35 citations

Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma

1987 • 30 citations

Phase II study of teniposide in small cell carcinoma of the lung.

1984 • 25 citations

Phase II trial of etoposide in previously treated small cell carcinoma of the lung.

1984 • 14 citations

Phase II study of oral VP-16-213 in small cell lung cancer

1987 • 13 citations

Cisplatin plus VP-16 in small-cell lung cancer.

1986 • 13 citations